This topic contains a solution. Click here to go to the answer

Author Question: There is no difference between a void contract and an unenforceable contract. Indicate whether the ... (Read 65 times)

jayhills49

  • Hero Member
  • *****
  • Posts: 559
There is no difference between a void contract and an unenforceable contract.
  Indicate whether the statement is true or false

Question 2

Which of the following is not a necessary element of promissory estoppel?
 A) The promisor and the promisee must engage in a bargained-for exchange.
 B) The promisor must intend or should reasonably expect that the promisee will rely on the promise.
 C) The promisee must in fact rely on the promise in some definite and substantial manner.
 D) Enforcement of the promise is the only way to avoid injustice.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

EAN94

  • Sr. Member
  • ****
  • Posts: 307
Answer to Question 1

FALSE

Answer to Question 2

A




jayhills49

  • Member
  • Posts: 559
Reply 2 on: Jun 24, 2018
YES! Correct, THANKS for helping me on my review


hollysheppard095

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library